Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses

cnbc.com/2025/07/09/hims-hers-generic-semaglutide-novo-nordisk-ozempic-wegovy-canada.html

Hims & Hers Health announced Wednesday it will offer generic semaglutide in Canada as Novo Nordisk's patent on its branded drugs Ozempic and Wegovy is set to expire in January.
"Canada is a major opportunity to show what affordable, high-quality weight loss care can look like," said…

This story appeared on cnbc.com, 2025-07-09 13:38:29.285000.
The Entire Business World on a Single Page. Free to Use →